Oncolytics Biotech Inc T.ONC

Alternate Symbol(s): ONCY

Healthcare Biotechnology

Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to registration-enabling clinical studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.

TSX:ONC - Post by User

Oncolytics Biotech Inc

Bullboard Posts

Comment by gbengaon Jan 14, 2020 3:14pm

213 Views

Post# 30552354

RE:5-year chart shows brief ONC annual January spikes and then

Predictable slide back to under $1

gbenga wrote: Been in ONC since 2014. while I am happy with the recent surge, a look at last fve years show exact same trend: end of year surge that fizzles and fades by mid-January. I sold a small position today just for peace of mind but till holding most of my position. DYODD

Bullboard Posts

The top 5 Canadian small-cap AI stocks